4 unknown, 3 completed, 1 not yet recruiting, 1 recruiting. 5 Phase 2, 3 Not applicable, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Unknown 2, Not yet recruiting 1 |
| Not applicable | 3 | Unknown 2, Completed 1 |
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 3 | 2 | Recruiting 1, Terminated 1 |
Follow Hemorrhagic Cystitis: new trials by email Literature Review of Hemorrhagic Cystitis trials Research Report on Hemorrhagic Cystitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Safety and Efficacy of LB-DTK-BKV in Patients With BK Virus-Associated Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation LB-DTK-BKV, Standard-of-care - Hemorrhagic Cystitis | Phase 1 / Phase 2 | Not yet recruiting | LucasBio | 42 | 2026-09-01 | 2026-07-24 |
| Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT Moxibustion, Symptomatic supportive treatment - Moxibustion, Hematopoietic Stem Cell Transplantation | Not applicable | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 60 | 2024-08-15 | 2024-07-24 |
| Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT Moxibustion, Symptomatic treatment - Moxibustion, Hematopoietic Stem Cell Transplantation | Not applicable | Completed | Yi Zhang | 303 | 2024-03-21 | 2026-08-24 |
| The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) Immunonutrition - Bladder Cancer, Interstitial Cystitis | Phase 3 | Recruiting | Centre Hospitalier Universitaire Vaudois | 232 | 2023-04-10 | 2025-12-09 |
| Chlorophyllin Tablets for Urinary Bleeding Following Radiation Therapy for Cancers of Pelvic Organs Sodium Copper Chlorophyllin - Hemorrhagic Cystitis | Phase 2 | Unknown | Tata Memorial Centre | 24 | 2022-03-26 | 2022-04-27 |
| Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC) Posoleucel (ALVR105), Placebo - BK Virus Infection, Hemorrhagic Cystitis | Phase 3 | Terminated | AlloVir | 97 | 2021-03-18 | 2024-05-14 |
| The Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic Cystitis LP-10 - Hemorrhagic Cystitis | Phase 2 | Completed | Lipella Pharmaceuticals, Inc. | 13 | 2020-10-01 | 2023-12-11 |
| Tolerability and Efficacy of INSTYLAN in Subjects With Moderate to Severe Hemorrhagic Cystitis INSTYLAN (Sodium Hyaluronate 80mg/50ml) - Hemorrhagic Cystitis | Not applicable | Unknown | LIDDE Therapeutics | 30 | 2020-05-15 | 2021-01-06 |
| A Double Blind Randomized Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis Decidual stromal cells, Placebo - Hemorrhagic Cystitis, Stem Cell Transplantation | Phase 2 | Unknown | Karolinska Institutet | 20 | 2014-03-01 | 2014-06-25 |
| A Pilot Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis Decidual Stromal Cell therapy - Hemorrhagic Cystitis | Phase 1 / Phase 2 | Completed | Karolinska Institutet | 12 | 2011-11-01 | 2014-06-24 |
Cystitis, Hemorrhagic (10) · Cystitis (1) · Cystitis, Interstitial (1) · Endometriosis (1) · Infections (1) · Malnutrition (1) · Urinary Bladder Diseases (1) · Urinary Bladder Neoplasms (1) · Urinary Bladder, Neurogenic (1) · Virus Diseases (1)
Female Urogenital Diseases (10) · Female Urogenital Diseases and Pregnancy Complications (10) · Male Urogenital Diseases (10) · Urogenital Diseases (10) · Urologic Diseases (10) · Cystitis (9) · Urinary Bladder Diseases (9) · Genital Diseases (1) · Genital Diseases, Female (1) · Neoplasms (1) · Neoplasms by Site (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1)
Moxibustion (2) · Immunonutrition Diet (1) · Standard of Care (1) · chlorophyllin (1)
Karolinska Institutet (2) · AlloVir (1) · Centre Hospitalier Universitaire Vaudois (1) · LIDDE Therapeutics (1) · Lipella Pharmaceuticals, Inc. (1) · LucasBio (1) · Tata Memorial Centre (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · Yi Zhang (1)
Sweden (3) · China (2) · France (2) · South Korea (2) · United States (2) · India (1) · Italy (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Dr. Gagan Prakash (1) · Eun Sun Yoo, MD-PhD (1) · Ho-joon Im, MD-PhD (1) · Hoon Kook, MD-PhD (1) · Hyeon Jin Park, MD-PhD (1) · Hyoung Jin Kang, MD-PhD (1) · Jae-Cheol Jo, MD-PhD (1) · Joonho Moon, MD-PhD (1) · Seung Min Hahn, MD-PhD (1) · Yae-Jean Kim, MD-PhD (1)